RUPATADINE

Empirical Formula: C26H26ClN3
Molecular Weight: 415.96
MDL number: MFCD00868381

What is RUPATADINE?

Clinical Use

Antihistamine

Drug interactions

Potentially hazardous interactions with other drugs
Antibacterials: concentration increased by clarithromycin and erythromycin - use with caution.
Antifungals: concentration increased by itraconazole, ketoconazole, posaconazole and voriconazole - avoid; use fluconazole with caution.
Antivirals: concentration possibly increased by ritonavir and other protease inhibitors - avoid.
Grapefruit juice: concentration increased - avoid.
Lipid-lowering agents: use in combination with statins with caution.
Ciclosporin, sirolimus, tacrolimus - concentration possibly increased by rupatadine.

Metabolism

Mainly metabolised by the cytochrome P450 (CYP 3A4) enzyme pathway. The amounts of unaltered active substance found in urine and faeces were insignificant. This means that rupatadine is almost completely metabolised.

Safety information for RUPATADINE

New Products

Paroxetine Impurity G/Paroxetine Related Compound E 1-Aminocyclopentane carbonitrile (RS)-beta-Amino-beta-(4-bromophenyl)propionic acid N,N CARBONYL DIIMIDAZOLE 2-Amino-5-bromo-4-(trifluoromethyl)pyridine（RM for Indian lab) Benzyl (3R,4S)-3-(2-bromoacetyl)-4-ethylpyrrolidine-1-carboxylate (R)-1-Benzyl-3-pyrrolidinecarbonitrile Betahistine EP Impurity C Cyclobenzaprine N-oxide/Citalopram Related Compound E Chlorthalidone Impurity I Carbamazepine EP Impurity G Sumatriptan Succinate USP Related Compound C 2,2'-(5-methyl-1,3-phenylene)-di(2-Methylpropionitrile) 4-Fluorothiophenol 1-methyl amino-2,4-dinitro benzene 5-Methyl-1,3-benzenediacetonitrile (R)-BoroLeu-(+)-Pinanediol-CF3COOH 4-(5-amino-1-methyl-1h-benzoimidazol-2-yl)-butyric acid isopropyl ester. 4-Bromo Benzylcyanide 3-Hydroxypropionitrile 3,4 Dimethoxy Benzylcyanide valeronitrile 3-chlorobenzyl cyanide 2-Chloro Benzylcyanide